Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,399 | 401 | 85.0% |
| Travel and Lodging | $998.92 | 5 | 11.5% |
| Education | $306.79 | 16 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,394 | 11 | $0 (2024) |
| ABBVIE INC. | $1,316 | 110 | $0 (2024) |
| Biogen, Inc. | $638.60 | 33 | $0 (2024) |
| EMD Serono, Inc. | $424.45 | 10 | $0 (2024) |
| PFIZER INC. | $368.63 | 39 | $0 (2024) |
| Lilly USA, LLC | $298.63 | 16 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $291.11 | 16 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $286.05 | 9 | $0 (2024) |
| Kyowa Kirin, Inc. | $263.66 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $224.11 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,951 | 147 | Abbott Laboratories ($1,348) |
| 2023 | $2,157 | 115 | ABBVIE INC. ($277.12) |
| 2022 | $1,698 | 105 | ABBVIE INC. ($390.23) |
| 2021 | $897.64 | 55 | Biogen, Inc. ($266.01) |
All Payment Transactions
422 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/19/2024 | Abbott Laboratories | INFINITY (Device) | Travel and Lodging | In-kind items and services | $175.77 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Abbott Laboratories | INFINITY (Device) | Travel and Lodging | In-kind items and services | $145.56 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Abbott Laboratories | INFINITY (Device) | Travel and Lodging | In-kind items and services | $66.35 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Abbott Laboratories | INFINITY (Device) | Travel and Lodging | In-kind items and services | $602.22 | General |
| Category: Neuromodulation | ||||||
| 12/12/2024 | Abbott Laboratories | INFINITY (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Neuromodulation | ||||||
| 12/11/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Neuromodulation | ||||||
| 12/10/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: PAIN | ||||||
| 12/03/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Neuroscience | ||||||
| 11/29/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $144.75 | General |
| Category: Neuromodulation | ||||||
| 11/26/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: Neuropsychiatry | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $31.92 | General |
| 11/19/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Rare Disease | ||||||
| 11/13/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 54 | 55 | $14,410 | $3,413 |
| 2022 | 5 | 190 | 262 | $104,440 | $14,373 |
| 2021 | 6 | 307 | 525 | $105,129 | $28,824 |
| 2020 | 8 | 338 | 481 | $83,676 | $23,559 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 44 | $9,900 | $2,345 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,510 | $1,068 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 80 | $18,825 | $4,443 | 23.6% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2022 | 30 | 55 | $33,850 | $3,513 | 10.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $11,470 | $3,112 | 27.1% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 30 | 54 | $33,925 | $1,767 | 5.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 44 | $6,370 | $1,537 | 24.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 144 | 184 | $32,936 | $9,853 | 29.9% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Office | 2021 | 35 | 98 | $22,176 | $7,170 | 32.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $14,476 | $4,270 | 29.5% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2021 | 34 | 98 | $20,951 | $3,314 | 15.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 27 | 77 | $8,470 | $2,616 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 24 | $6,120 | $1,601 | 26.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 157 | 226 | $32,996 | $9,516 | 28.8% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Office | 2020 | 30 | 66 | $14,325 | $4,818 | 33.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 44 | 44 | $14,124 | $4,170 | 29.5% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2020 | 30 | 66 | $13,436 | $2,260 | 16.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 18 | 19 | $2,235 | $847.78 | 37.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 14 | $2,982 | $814.76 | 27.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 27 | 28 | $2,464 | $781.58 | 31.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 18 | 18 | $1,114 | $351.95 | 31.6% |
About Rose Soto, NP
Rose Soto, NP is a Adult Health healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376591099.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rose Soto, NP has received a total of $8,704 in payments from pharmaceutical and medical device companies, with $3,951 received in 2024. These payments were reported across 422 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($7,399).
As a Medicare-enrolled provider, Soto has provided services to 889 Medicare beneficiaries, totaling 1,323 services with total Medicare billing of $70,168. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Syracuse, NY
- Active Since 05/05/2006
- Last Updated 10/13/2007
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1376591099
Products in Payments
- INFINITY (Device) $1,394
- QULIPTA (Drug) $495.03
- UBRELVY (Drug) $485.36
- NURTEC ODT (Drug) $478.61
- TYSABRI (Biological) $410.78
- INGREZZA (Drug) $291.11
- ULTOMIRIS (Biological) $247.47
- Nourianz (Drug) $228.54
- KESIMPTA (Drug) $211.09
- DUOPA (Drug) $173.92
- RYTARY (Drug) $165.27
- REXULTI (Drug) $147.28
- VYEPTI (Biological) $137.72
- AUSTEDO (Drug) $136.62
- BOTOX (Biological) $134.82
- EMGALITY (Drug) $129.05
- NUPLAZID (Drug) $121.17
- Mavenclad (Drug) $117.36
- APTIOM (Drug) $113.19
- BRIUMVI (Drug) $104.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Syracuse
Ms. Linda Casey, Rnnp, RNNP
Adult Health — Payments: $4,714
Ms. Susan Lipsy, R.n. Ms. C.u.n.p, R.N. MS. C.U.N.P
Adult Health — Payments: $3,329
Kathryn Cooper, Np, NP
Adult Health — Payments: $2,454
Mrs. Patti-Ann Kick, Msn, Anp-C, MSN, ANP-C
Adult Health — Payments: $1,112
Deborah Pflugh, Np, NP
Adult Health — Payments: $941.83
Mrs. Karen Boulos, Anp, ANP
Adult Health — Payments: $635.48